Template:Hypertrophic cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(31 intermediate revisions by 3 users not shown) | |||
Line 23: | Line 23: | ||
! | ! | ||
[[Hypertrophic cardiomyopathy overview|Overview]] | [[Hypertrophic cardiomyopathy overview|Overview]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Hypertrophic cardiomyopathy historical perspective|Historical Perspective]] | |||
|- | |- | ||
! | ! | ||
Line 34: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy pathophysiology|Pathophysiology]] | |||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Hypertrophic cardiomyopathy causes|Causes]] | |||
|- | |||
|- | |||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy differential diagnosis|Differentiating Hypertrophic Cardiomyopathy from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 54: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 60: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 66: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 72: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy natural history|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 84: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy diagnostic study of choice|Diagnostic Study of Choice]] | ||
|- | |- | ||
! | ! | ||
Line 90: | Line 94: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 96: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy physical examination|Physical Examination]] | ||
|- | |- | ||
! | ! | ||
Line 102: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 108: | Line 112: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy electrocardiogram|Electrocardiogram]] | ||
|- | |- | ||
! | ! | ||
Line 114: | Line 118: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy x ray|X Ray]] | ||
|- | |- | ||
! | ! | ||
Line 120: | Line 124: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy echocardiography|Echocardiography]] | [[Hypertrophic cardiomyopathy echocardiography and ultrasound|Echocardiography and Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 126: | Line 130: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy CT scan|CT scan]] | ||
|- | |- | ||
! | ! | ||
Line 132: | Line 136: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
Line 138: | Line 142: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy other imaging findings|Other Imaging Findings]] | ||
|- | |- | ||
! | ! | ||
Line 156: | Line 160: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy medical therapy|Medical Therapy]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Hypertrophic cardiomyopathy interventions|Interventions]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Hypertrophic cardiomyopathy surgery|Surgery]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Hypertrophic cardiomyopathy primary prevention|Primary Prevention]] | |||
|- | |- | ||
! | ! | ||
Line 166: | Line 184: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy secondary prevention|Secondary Prevention]] | |||
|- | |- | ||
! | ! | ||
Line 177: | Line 190: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy | [[Hypertrophic cardiomyopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 183: | Line 196: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Hypertrophic cardiomyopathy Future or investigational therapies|Future or Investigational Therapies]] | |||
|- | |- | ||
! | |||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Hypertrophic cardiomyopathy case study one|Case #1]] | |||
|- | |||
! | ! | ||
Latest revision as of 15:23, 10 March 2020
Hypertrophic Cardiomyopathy Microchapters |
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hypertrophic cardiomyopathy On the Web |
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
Risk calculators and risk factors for Hypertrophic cardiomyopathy |